Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (1,464,000)	$ (2,638,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	391,000	311,000
Loss on sale of property and equipment	98,000	0
Loss on impairment of right-of-use lease assets	363,000	0
Accretion of discount on investments	(723,000)	0
Stock-based compensation	233,000	298,000
Changes in operating assets and liabilities:
Accounts receivable	(1,718,000)	300,000
Contract assets	(376,000)	(5,000)
Prepaid expenses and other assets	13,000	(191,000)
Third-party software fees payable	(147,000)	425,000
Accounts payable and accrued expenses	(272,000)	(248,000)
Deferred revenue	(129,000)	(749,000)
Net cash used in operating activities	(3,731,000)	(2,497,000)
Cash flows from investing activities:
Additions to property and equipment	(149,000)	(406,000)
Proceeds from short-term investments	31,750,000	0
Purchases of short-term investments	(53,816,000)	(10,677,000)
Net cash used in investing activities	(22,215,000)	(11,083,000)
Cash flows from financing activities:
Proceeds from exercise of stock options	26,000	79,000
Cash settlement of performance stock units	0	(137,000)
Repurchases of common stock	(659,000)	0
Net cash used in financing activities	(633,000)	(58,000)
Effect of exchange rate changes on cash and cash equivalents	(18,000)	(62,000)
Net decrease in cash and cash equivalents	(26,597,000)	(13,700,000)
Cash, restricted cash, and cash equivalents, beginning of period	35,635,000	40,086,000
Cash, restricted cash, and cash equivalents, end of period	$ 9,038,000	$ 26,386,000